Stanford University
Showing 481-500 of 512 Results
-
Doug Owens
Henry J. Kaiser, Jr. Professor, Senior Fellow at the Freeman Spogli Institute for International Studies and Professor, by courtesy, of Management Science and Engineering
Current Research and Scholarly InterestsMy research uses decision modeling, cost-effectiveness analysis, and meta-analysis to evaluate clinical and health policy problems. Much of my work involves development of national guidelines for prevention and treatment.
-
Philip Oyer
Roy B. Cohn-Theodore A. Falasco Professor of Cardiothoracic Surgery, Emeritus
Current Research and Scholarly InterestsDevelopment of an artificial heart assist device; heart, and heart-lung transplantation.
-
Michelle Ozaki
Postdoctoral Scholar, Genetics
Current Research and Scholarly InterestsResearch interests include tumor microenvironment interactions, stromal and tumor cell interactions, and how stromal cells impact metastasis.
-
Ekin Gunes Ozaktas
Ph.D. Student in Electrical Engineering, admitted Autumn 2024
Masters Student in Electrical Engineering, admitted Summer 2026
Ph.D. Minor, PhysicsBioI am a PhD candidate and Stanford Graduate Fellow at Stanford University working with Prof. Shanhui Fan.
Contact: eozaktas [at] stanford [dot] edu -
Michael G. Ozawa
Clinical Associate Professor, Pathology
BioDr. Ozawa is a Clinical Associate Professor of Pathology with subspecialty focus in Cytopathology, Head and Neck pathology, and Thoracic pathology. He completed his M.D., Ph.D. training at the McGovern Medical School and the M. D. Anderson Cancer Center in Houston, TX. He then completed residency training in Anatomic and Clinical Pathology followed by fellowship training in Surgical Pathology and Cytopathology at Stanford University. He is board certified in Anatomic and Clinical Pathology as well as Cytopathology. His interests include pulmonary neoplasms as well as neoplasms of the Head and Neck. He also has developed collaborative research interests in utilizing fine needle aspiration (FNA) techniques in the growing clinical application of Chimeric Antigen T Cell (CAR-T) therapy.
